Almac Group Limited

Almac Group Limited is a contract development and manufacturing organization (CDMO) providing comprehensive drug development and commercialization services to the global pharmaceutical and biotechnology industries. Headquartered in Craigavon, Northern Ireland, the company operates 18 facilities across Europe, North America, and Asia Pacific to serve global biopharmaceutical partners. Its primary service portfolio spans active pharmaceutical ingredient (API) development and manufacture, custom peptide synthesis, biocatalysis solutions, and early-to-late-phase drug product formulation. Almac provides extensive analytical testing, solid-state services, and commercial-scale drug manufacturing and specialized packaging solutions. The organization delivers integrated clinical trial supply chain services, including global logistics, storage, distribution, commercial drug procurement, and temperature-controlled cold chain management. Through its eClinical division, Almac supplies clinical technologies such as Interactive Response Technology (IRT), eCOA, and eConsent software solutions. The company's diagnostic division offers precision medicine services, clinical biomarker development, genomic testing, companion diagnostics (CDx), and CLIA and CAP accredited laboratory testing.